161 related articles for article (PubMed ID: 30241225)
1. Availability of WHO Essential Medicines for Cancer Treatment in Botswana.
Martei YM; Chiyapo S; Grover S; Ramogola-Masire D; Dryden-Peterson S; Shulman LN; Tapela N
J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241225
[TBL] [Abstract][Full Text] [Related]
2. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
[TBL] [Abstract][Full Text] [Related]
3. Determinants of access to childhood cancer medicines: a comparative, mixed-methods analysis of four Caribbean countries.
Boateng R; Petricca K; Tang B; Parikh S; SinQuee-Brown C; Alexis C; Browne-Farmer C; Reece-Mills M; Salmon SM; Bodkyn C; Gupta S; Maguire B; Denburg AE
Lancet Glob Health; 2021 Sep; 9(9):e1314-e1324. PubMed ID: 34416215
[TBL] [Abstract][Full Text] [Related]
4. Anticancer medicines in Pakistan: An analysis of essential medicines lists.
Shukar S; Anjum R; Zhang J; Babar ZU; Mobeen I; Yang C
J Oncol Pharm Pract; 2024 Jan; 30(1):46-54. PubMed ID: 37006130
[TBL] [Abstract][Full Text] [Related]
5. Health system determinants of access to essential medicines for children with cancer in Ghana.
Boateng R; Renner L; Petricca K; Gupta S; Denburg A
BMJ Glob Health; 2020 Sep; 5(9):. PubMed ID: 32967979
[TBL] [Abstract][Full Text] [Related]
6. The interpretation of China national essential medicines list 2018.
Zuo W; Mei D; Sun W; Tang X; Niu Z; Gao D; Zhang B
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):191-200. PubMed ID: 31914825
[No Abstract] [Full Text] [Related]
7. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list.
Naicker I; Suleman F; Perumal-Pillay VA
J Pharm Policy Pract; 2022 Dec; 15(1):97. PubMed ID: 36482421
[TBL] [Abstract][Full Text] [Related]
8. Impact of Essential Medicine Stock Outs on Cancer Therapy Delivery in a Resource-Limited Setting.
Martei YM; Grover S; Bilker WB; Monare B; Setlhako DI; Ralefala TB; Manshimba P; Gross R; Shulman LN; DeMichele A
J Glob Oncol; 2019 Apr; 5():1-11. PubMed ID: 30969808
[TBL] [Abstract][Full Text] [Related]
9. Methodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income Countries.
Martei YM; Chiyapo S; Grover S; Hanna C; Dryden-Peterson S; Pusoentsi M; Shulman LN; Tapela N
J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241244
[TBL] [Abstract][Full Text] [Related]
10. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
11. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
12. Availability of essential medicines: A primary health care perspective.
Dixit R; Vinay M; Jayasree T; Ubedulla S; Manohar VS; Chandrasekhar N
Indian J Pharmacol; 2011 Sep; 43(5):599-600. PubMed ID: 22022009
[TBL] [Abstract][Full Text] [Related]
13. Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China.
Tang Y; Liu C; Zhang X
Appl Health Econ Health Policy; 2017 Feb; 15(1):57-64. PubMed ID: 27613726
[TBL] [Abstract][Full Text] [Related]
14. Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.
Kizub DA; Naik S; Abogan AA; Pain D; Sammut S; Shulman LN; Martei YM
Oncologist; 2022 Nov; 27(11):958-970. PubMed ID: 36094141
[TBL] [Abstract][Full Text] [Related]
15. The role of government agencies and other actors in influencing access to medicines in three East African countries.
Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH
Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583
[TBL] [Abstract][Full Text] [Related]
16. GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.
Piggott T; Moja L; Jenei K; Kredo T; Skoetz N; Banzi R; Trapani D; Leong T; McCaul M; Lavis JN; Akl EA; Nonino F; Iorio A; Laurson-Doube J; Huttner BD; Schünemann HJ
J Clin Epidemiol; 2024 Feb; 166():111241. PubMed ID: 38123105
[TBL] [Abstract][Full Text] [Related]
17. Availability, Costs and Stock-Outs of Essential NCD Drugs in Three Rural Rwandan Districts.
Mukundiyukuri JP; Irakiza JJ; Nyirahabimana N; Ng'ang'a L; Park PH; Ngoga G; El-Khatib Z; Nditunze L; Dusengeyezu E; Rusangwa C; Mpunga T; Mubiligi J; Hedt-Gauthier B
Ann Glob Health; 2020 Sep; 86(1):123. PubMed ID: 33024709
[TBL] [Abstract][Full Text] [Related]
18. Access to WHO Essential Medicines for Childhood Cancer Care in Trinidad and Tobago: A Health System Analysis of Barriers and Enablers.
Tang B; Bodkyn C; Gupta S; Denburg A
JCO Glob Oncol; 2020 Feb; 6():67-79. PubMed ID: 32031441
[TBL] [Abstract][Full Text] [Related]
19. Understanding human resource management practices in Botswana's public health sector.
Seitio-Kgokgwe OS; Gauld R; Hill PC; Barnett P
J Health Organ Manag; 2016 Nov; 30(8):1284-1300. PubMed ID: 27834603
[TBL] [Abstract][Full Text] [Related]
20. Availability of Pediatric Formulations in Public Health Care System in India: A Case Study.
Roy V; Singhal S; Tayal H; Dubey AP
Indian J Pediatr; 2021 Mar; 88(3):227-234. PubMed ID: 32086758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
